Abstract
dc:descriptionIntroduction Subthalamic deep brain stimulation (DBS) has become the standard surgical therapy for medically refractory Parkinson Disease (PD) since stimulation of the STN improves all cardinal features of PD. Despite the wide acceptance of the deep brain stimulation (DBS), there is considerable variability in the technical approach and several issues remain controversial. An important issue is whether the insertion of bilateral DBS electrodes or the use of multiple simultaneous tracts for the microelectrode recordings (MERs) is associated with a higher risk of brain damage such as hemorrhage, contusion or even not detectable by imaging damage. S-100b protein has been established as the most reliable so far biochemical marker of brain damage and a prognosticator of response to therapy. Moreover there is still debate about the necessity of the utilization of the microelectrode recordings or the use 5 simultaneous tracks for the microelectrode recordings. Furthermore, the optimal targeting technique is a subject of controversy. The aim of this study was 1) Present the results of DBS in STN in 59 patients and to analyze the surgical morbidity and mortality of the procedure.2) Evaluate whether brain damage is caused during the passing of i) microrecording electrodes, ii) macrostimulation electrodes or iii) permanent stimulation electrodes.3) Examine whether there is any relationship between the number of inserted electrodes and brain injury or morbidity.4) Evaluate the differences between the coordinates of the lead’s final location with those of the predicted location and the standard coordinates.5) Define the role of the intraoperative electrophysiological recording in targeting STN.Patients - MethodsBetween 2004 and 2008, we implanted 117 DBS systems in 59 patients. Mean age of patients was 61,4 years (38-75 years) and the average duration of the disease was 15,1 years (7-29 years). The clinical rating tests included: the unified Parkinson’s disease rating scale (UPDRS), the Hoehn and Yahr and the Swab and England scales. The quality of life was assessed with the Parkinson’s Disease Questionnaire 39 (PDQ39). Preoperatively, all patients were assessed in “on” and “off” condition and postoperative evaluations were performed at 6 and 12 months in medication “on” and “off” condition and stimulation “on” and “off” condition. Targeting of the STN was performed by direct visualization of the nucleus in the fused stereotactic CT / preoperative MRI. We then proceeded to indirect targeting using the standard geometric coordinates; the target was correlated to the electronic version of the Schaltenbrand and Warhen atlas. We used an array of five microelectrodes separated by 2mm for MERs. Final location was selected according to the results of intraoperative MERs and macrostimulation. All patients underwent measurements of serum S-100b as follows: 1) prior to the operation 2) after the burr hole opening 3) after insertion of microrecording electrodes, 4) during macrostimulation, 5) at the end of the operation and 6) on the 1st postoperative dayResultsBilateral STN-DBS resulted in a significant reduction in UPDRS motor scores, in Hoehn and Yahr and the Swab and England. The quality of life improved in the majority of the patients. Complications occurred in 10 patients; these included: infection, hemorrhage, pulmonary embolism and epileptic seizures. All complications were managed conservatively and the patients recovered without any permanent sequelae. No perioperative death occurred. The anterior-posterior and vertical values of the predicted location were significantly different from those of the target in the atlas; anterior-posterior: absolute range 0.7-4.10, p<0.05; lateral; absolute range 9.8-12.9, p<0.05. There was no statistical difference in the vertical value (p>0.05). The predicted location was used in 37% of the cases but was modified by MERs in the remaining 63%. We found that S-100B protein was increased in only two cases. In all other cases, serum S-100b protein values remained within the normal range. No relationship was found between the number of inserted electrodes and the complicationsConclusions: The results of this study prove that: 1)The insertion of either DBS electrodes or recording electrodes does not cause any detectable brain injury. Furthermore the results indicate that there is no statistically significant difference between the number of electrodes used and either the risk of brain damage or the morbidity of movement disorders surgery. 2)The combined use of all available targeting methods is important for the optimal insertion of the DBS lead.3)The use of the microelectrode recordings is necessary for the optimal DBS placement.4)Five simultaneous tracks provide more detailed information about the topography of the STN and result in better motor outcome.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2008
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Themistokleous, Marios
- Θεμιστοκλέους, Μάριος
Subjects
dc:subject × 20- Εν τω βαθεί εγκεφαλική διέγερση
- Νόσος Πάρκινσον
- Υποθαλαμικός πυρήνας
- Ωχρά σφαίρα
- Πρωτεΐνη S100b
- Μετεγχειρητική εγκεφαλική βλάβη
- Μικροηλεκτρόδια
- Deep brain stimulation
- Parkinson's disease
- Subthalamic nucleus
- Globus pallidus
- S100-B protein
- Brain injury
- Microelectrodes
- Κλινική Ιατρική
- Ιατρική και Επιστήμες Υγείας
- Κλινική ιατρική, άλλοι τομείς
- Clinical Medicine
- Medical and Health Sciences
- Clinical medicine, miscellaneous
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/53497